Due to health issues, this site is no longer maintained and will be shut down shortly.

HCM Hutchison China Meditech ADRs

Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:HCM.

$13.93  +0.19 (1.38%)
As of 03/27/2023 12:44:23 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  Cayman Islands
IPO date:  03/16/2016
Outstanding shares:  172,955,000
Average volume:  331,024
Market cap:   $2,455,961,000
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BYXV9H7
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy